Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow solutions

RDNT

ICAD

<p>收购增强了 iCAD 的商业、技术和监管能力。这项收购使 DeepHealth 具备了一套行业领先的基于人工智能的乳腺癌影像解读和工作流程解决方案</p>

RadNet 的全资子公司 DeepHealth 完成了对 ICAD 的收购